Skip to content
CH

Core Healthcare

COREPARENT NSE
Price unavailable

In the Sep 2025 quarter, revenue was ₹78 Cr, against ₹68 Cr a year earlier and net profit was ₹2 Cr, against ₹6 Cr a year earlier (compared with Sep 2024). Promoters held 69.98% of Core Healthcare in Sep 2025, unchanged from Mar 2025.

No price data available

Peer Comparison

Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹1,767.5035.064,24,082 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
₹4,607.8072.341,75,266 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
₹2,187.30108.071,18,182 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
₹1,181.8026.301,17,885 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
₹1,339.3034.691,11,789 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
₹1,365.2032.711,10,289 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Core Healthcare (this company)
———————281 Cr15 Cr
Median 8 companies₹1,767.5035.061,18,182 Cr5.070.61%13.79%17.94%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company has reduced debt.

Growth Rate

Revenue Growth
-100%

change over 1 year

Net Income Growth
129%

change over 1 year

Quarterly Results

Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Sales
69
62
68
66
78
Expenses
58
56
61
59
72
Operating Profit
11
6
7
7
6
OPM %
16%
9%
10%
10%
8%
Other Income
-1
2
1
1
2
Interest
1
2
1
2
3
Depreciation
1
1
1
2
3
PBT
8
6
6
4
2
Tax %
25%
32%
0%
59%
0%
Net Profit
6
4
6
1
2
EPS (₹)
4.75
2.24
3.34
0.84
1.36
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007
Sales
38.58
0
Expenses
60.22
8.47
Operating Profit
-21.64
-8.47
OPM %
-56.09%
—
Other Income
1.6
-0.2
Interest
1.53
0.03
Depreciation
43.3
1.13
PBT
-64.87
-9.83
Tax %
0.03%
0.1%
Net Profit
-64.89
-9.84
Div. Payout %
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007
Equity Capital
33.99
33.99
Reserves
-1,060
-177
Borrowings
1,845
151
Other Liabilities
55.37
6.11
Total Liabilities
874
14.07
Fixed Assets
481
13.26
CWIP
70.65
0
Investments
41.1
0
Other Assets
281
0.81
Total Assets
874
14.07
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007
Operating
-3.21
-5.09
Investing
-1.16
2.65
Financing
3.07
0.5
Net Cash Flow
-1.3
-1.94
Free Cash Flow
-5.51
-4.55
CFO/EBITDA
15
60
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007
Debtor Days
21.95
—
Inventory Days
2.04
—
Days Payable
31.87
—
Cash Conversion Cycle
-7.87
—
Working Capital Days
-2.46
—
ROCE %
—
4.5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Core Healthcare insights

29 extracted metrics + investor summaries across FY06–FY26.

Shareholding Pattern

Promot.69.98%Public30.02%As ofSep 2025

Documents

Frequently Asked Questions about Core Healthcare

Where is Core Healthcare Ltd (COREPARENT) listed?
Core Healthcare Ltd trades as COREPARENT on the NSE.
Which sector does Core Healthcare Ltd belong to?
Core Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COREPARENT.md for Core Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More